argenx SE
ARGX
925.70
-16.34
-1.73%
argenx SE
US · ARGX
#369 by market cap
Listed 2017
925.70
-16.34
-1.73%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
About argenx SE
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.
- Founded
- 2008
- CEO
- Mr. Tim Van Hauwermeiren, M. Sc.
- Employees
- 3,522
- Headquarters
- Amsterdam, Noord-Holland, Netherlands (the)
- Fiscal year end
- 12-31
- Website
- argenx.com
Company profile
- Exchange
- US
- Symbol
- ARGX
- Market-cap rank
- #369
- Listing date
- 2017-05-18
- Market cap
- 58.21B
- Float cap
- 58.12B
- Shares out
- 62.89M
- Float shares
- 62.78M
Sectors & themes
Biotechnology
Fractional Shares JP
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
argenx SE discussion 0 comments